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Abstract
Background Factors mediating the invasion of pancreatic cancer cells through the
extracellular matrix (ECM) are not fully understood. Methods In this study, sub-
populations of the human pancreatic cancer cell line, MiaPaCa-2 were established
which displayed differences in invasion, adhesion, anoikis, anchorage-independent
growth and integrin expression. Results Clone #3 displayed higher invasion with less
adhesion, while Clone #8 was less invasive with increased adhesion to ECM proteins
compared to MiaPaCa-2. Clone #8 was more sensitive to anoikis than Clone #3 and
MiaPaCa-2, and displayed low colony-forming efficiency in an anchorage-
independent growth assay. Integrins beta 1, alpha 5 and alpha 6 were over-expressed
in Clone #8. Using small interfering RNA (siRNA), integrin β1 knockdown in Clone
#8 cells increased invasion through matrigel and fibronectin, increased motility,
decreased adhesion and anoikis. Integrin alpha 5 and alpha 6 knockdown also resulted
in increased motility, invasion through matrigel and decreased adhesion. Conclusion
Our results suggest that altered expression of integrins interacting with different
extracellular matrixes may play a significant role in suppressing the aggressive
invasive phenotype. Analysis of these clonal populations of MiaPaCa-2 provides a
model for investigations into the invasive properties of pancreatic carcinoma.
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Background
Pancreatic cancer is a devastating disease; it is the eighth most common cause of
death (from cancer in both sexes combined) in the World, and is responsible for
227,000 deaths per year [1]. The median survival time after tumour detection is 3-6
months [2], with an all-stage 5-year survival rate of < 5% [3]. Surgery offers the best
possibility for survival but at time of diagnosis, only 15% of patients are eligible for
resection [4]. The poor outcome is mainly due to difficulties in early detection, lack of
an effective treatment and limited understanding of the biological characteristics of
this disease. Intrinsic resistance to chemotherapy and radiation [5] coupled with its
early systematic dissemination, local tumour progression and metastatic propensity
are associated with pancreatic cancer [6].
The processes involved in tumour cell invasion and metastasis are complex. The
ability of cancer cells to degrade and adhere to the basement membrane and
metastasise to distant organs is one of the most critical aspects of cancer. Adhesion
molecules, such as integrins mediate direct cell-cell recognition and cell-matrix
interactions [7] are essential for tumour cell migration [8] and for basement
membrane penetration [9]. In pancreatic cancer, expression of integrins α6β1 [10-12]
and αvβ3 [13] have previously been associated with invasion in cell lines and tissues.
However, contrasting results with respect to tumour type and integrin expression
patterns makes it difficult to draw general conclusions on the role of specific
integrins. Tumour progression and metastasis are associated with changes in a
multitude of integrin signalling cascades. Transformed cancer cells are often
characterised by the loss/reduction of integrin expression [14, 15]. Extracellular
matrix (ECM)-ligand binding to an integrin initiates signals, which are transmitted via
different, yet interconnecting, pathways and elicit various cell functions, such as
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morphological changes, adhesion, migration and gene activation, all relevant to the
metastatic cascade. The surrounding microenvironment and adhesion properties of
pancreatic tumours and sub-populations within the tumour may determine which
integrins increase or reduce metastasis in particular tumours [16]. Advanced tumours
often contain a variety of sub-populations, which have differing metastatic potential
[17]. Li et al. [18] identified a highly tumourigenic sub-population of pancreatic
cancer cells expressing the cell surface markers CD44, CD24, and epithelial-specific
antigen (ESA) capable of self-renewal and increased tumourigenic potential. The
identification of pancreatic cancer stem cells has many significant implications for the
treatment of pancreatic cancer.
Therefore, in this study, we isolated clonal isogenic sub-populations, derived from the
original pancreatic cancer cell line, MiaPaCa-2. Clone #3 and Clone #8 exhibit
identical genetic fingerprints with different malignancy-related phenotypes. We
examine how altered integrin expression including β1, α5 and α6 affects invasion,
motility, adhesion and anoikis using RNAi. Furthermore, the role of integrins in the
aggressive invasive phenotype, which correlates with in vitro malignant
transformation in this pancreatic cancer cell line model, could help to define an
invasion/metastatic-related model for pancreatic cancer.
Methods
Cell lines
The human pancreatic cell line MiaPaCa-2 was obtained from the European
Collection and Cell Cultures (ECACC, UK). Clone #3 and Clone #8 were obtained by
limitation dilution cloning in this laboratory, adapted from [19]. The parental cell line
was diluted to a concentration of 3 cells/ml and 100 µl plated onto each well of a 96-
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well plate. After 24 hours each well was studied for single cells, which were allowed
to grow into colonies. Once confluence was achieved, cells were transferred to a T25-
T75 cm3 flask within 2 weeks. The colonies were then screened by invasion assay to
assess their invasive abilities. Cells were maintained in a humidified atmosphere
containing 5 % CO2 at 37o C in Dulbecco’s modified Eagles medium (DMEM)
supplemented with 5 % foetal bovine serum (Sigma-Aldrich). Antibiotics were not
used in the growth media. All cell lines were free from Mycoplasma as tested with the
indirect Hoechst staining method.
Invasion and Motility assays
Invasion assays were performed using an adapted method [20]. Matrigel was diluted
to 1 mg/ml in serum free DMEM. Laminin, fibronectin and collagen type IV was
diluted to 25 µg/ml in PBS and collagen type I to 10 µg/ml. 100 µl of ECM protein
was placed into each insert (Falcon) (8.0 µm pore size), in a 24-well plate (Costar).
The ECM coated inserts were incubated overnight at 4o C. The following day, the
ECM was allowed polymerise at 37o C for 1 hr. The inserts were then washed with
serum-free DMEM, 100 µl of complete DMEM was added to the wells and 1x105/100
µl cells were then seeded onto the insert. 500 µl of complete DMEM was added into
the underside of the well. After 24 hours incubation, the inside of the insert was wiped
with a wet cotton swab. The under surface was gently rinsed with PBS and stained
with 0.25% crystal violet for 10 minutes, rinsed again with sterile water and allowed
to dry. To determine total number of invading cells, the inserts were then viewed
under the microscope and the number of cells/field in 10 random fields were counted
at 200× magnification. The average number of cells/field was then multiplied by a
factor of 140 (growth area of membrane/field area viewed at 200× magnification
(calibrated using a microscope graticule)). The mean values were obtained from a
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minimum of three individual experiments and were subjected to t-tests and ANOVA.
Motility assays were carried out in the same manner as invasion assays without the
addition of ECM on the insert. Experiments were performed in triplicate.
Adhesion assay
Adhesion assays were performed using a modified method [21]. 24-well plates were
coated with 250 µl of 25 µg/ml ECM proteins (laminin, fibronectin and collagen type
IV), 10 µg/ml of collagen type I and 1 mg/ml of matrigel. ECM proteins were
incubated overnight at 4o C. To reduce non-specific binding, 0.5 ml of 0.1 % BSA-
PBS solution was added to each well and incubated for 20 minutes, then rinsed twice
with sterile PBS. A single cell suspension was obtained, 1 ml of a 2.5x104 cell
suspension was added onto the pre-coated 24-well plates in triplicate and allowed to
attach for 60 minutes. Blank wells contained ECM proteins but no cells; controls were
uncoated wells with cells. After 60 minutes, the non-adhered cells were removed by
washing twice with sterile PBS. 200 µl of freshly prepared phosphatase substrate (10
mM p-nitrophenol phosphate in 0.1 M sodium acetate, 0.1% Triton X-100 pH 5.5)
was added to each well. Plates were then incubated in the dark at 37o C for 2 hours.
The enzymatic reaction was stopped by the addition of 100 µl 1 M NaOH. The
absorbance was read on a BIO-TEK plate reader at 405 nm with a reference
wavelength of 620 nm.
Anoikis assay
24-well plates were coated with 200 µl of poly-2-hydroxyethyl methacrylate (poly-
HEMA, 12 mg/ml dissolved in 95% ethanol, Sigma) and allowed to dry overnight. 1
ml of a single cell suspension of 1x105 cells was plated onto standard 24 well plates or
poly-HEMA coated plates. After 24 hours incubation at 37o C in a humidified
atmosphere containing 5% CO2, the viability of cells was quantitatively measured
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using alamarBlue indicator dye (Serotec). The absorbance was read on a BIO-TEC
plate reader at 570 nm with a reference wavelength of 600 nm.
Soft agar colony-forming assay
Soft agar assays or anchorage independent growth assays were carried out using a
modified method [22]. 1.548 g of agar (Bacto Difco, 214040) was dissolved in 100 ml
of ultra pure water and autoclaved. This agar was then melted in a microwave oven
immediately prior to use and incubated at 44o C. 50 ml of agar was then added to 2x
DMEM AgarMedium (AgM), mixed well and quickly dispensed onto 35 mm sterile
petri dishes. The plates were allowed to set at room temperature and the remaining
AgM was returned to the water bath with the temperature reduced to 41oC. 10% FCS
was added to the AgM. Cells were harvested and resuspended in medium without
serum, ensuring that a single cell suspension was obtained. The cells were diluted to 2
x 104 cells/ml in a total of 5 ml. 5 ml of agar was then added to each suspension,
mixed well and 1.5 ml was dispensed onto each pre-set agar plate, in triplicate, giving
a final concentration of 1.5 x 104 cells per plate. The plates were placed on trays
containing a small volume of water to prevent the agar from drying out. On day 0,
cells were counted and subsequently cultured for an additional 10 days. After this
time the colonies were counted using an inverted microscope at 400×. Ten areas were
viewed per plate and the total number of colonies present was extrapolated and the
percentage colony forming efficiency (CFE) was determined by expressing the
number of colonies formed after 10 days as a percentage of the number of cells
counted on day 0.
Immunoblotting
Whole protein was extracted from cell lysates using 1x lysis buffer (50 mM Tris-Cl,
150 mM NaCl, and 0.5% NP-40). Lysates were centrifuged for 10 min at 14,000 rpm
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at 4o C. Protein concentrations were determined using the Bio-Rad protein assay
according to manufacturer’s instructions (Bio-Rad). 35 µg of protein was separated by
7.5% SDS-PAGE under reducing conditions. Proteins were transferred to
nitrocellulose membrane (Amersham). Membranes were blocked at 4 oC overnight in
TBS (25mM Tris-HCl, pH 7.4, 150mM NaCl, 2.7mM KCl) containing 5% (w/v)
lowfat milk powder. Membranes were probed with specific antibodies. Anti-β1
(MAB1951Z-20), anti-α5 (AB1949) and anti-α6 (MAB1982) were obtained from
Chemicon (Millipore, Europe). Beta-actin was used as loading control (Sigma,
A5441). Membranes were washed 3× for 5 min with PBS-Tween-20 (0.1%) and
incubated with secondary antibodies, anti-mouse and anti-rabbit (Sigma) for 1 hr at
room temperature and washing step repeated. Protein bands were detected with
Luminol reagent (Santa Cruz Biotechnology).
Integrin siRNA transfection
Two integrin β1 (ITGB1) target siRNAs (#109877, #109878 (validated) Ambion Inc.)
were used to silence integrin β1 expression. Two integrin α5 (ITGA5) target siRNAs
(#106728, #111113 Ambion Inc.) and two integrin α6 (ITGA6) target siRNAs
(#8146, #103827 (validated) Ambion Inc.) were used to silence the respective target
genes. Solutions of siRNA at a final concentration of 30 nM were prepared in
OptiMEM (GibcoTM). NeoFX solution was prepared in OptiMEM and incubated at
room temperature for 10 min. After incubation, an equal volume of neoFX solution
was added to each siRNA solution, mixed well and incubated for a further 10 min.
100 µl of neoFX/OptiMEM solutions were added into a 6 well plate in duplicate.
Clone #8 (3x105) cells were added onto the siRNA solution. The plates were gently
mixed and incubated for 24 hours. The transfection mixture was removed and
replaced with fresh medium. Positive control, kinesin (Ambion Inc.) was included in
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each triplicate experiment. Invasion, motility, adhesion and anoikis assays were then
carried out 48 hours after transfection, as previously described.
Statistical analysis
Student’s t-test was used for statistical analyses of invasion, motility, adhesion,
anoikis and soft agar assays. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.005 indicated
statistical significance. Data are presented as mean ± standard deviation. Each
experiment was repeated at least three times. Multiple group comparison experiments
were validated by ANOVA.
Results
Single cell cloning
Four clones were isolated from the pancreatic cell line, MiaPaCa-2 and successfully
established as cell lines. The invasion status of the clones was tested using the Boyden
chamber assay with inserts coated with matrigel. Two sub-populations, Clone #3 and
Clone #8, showed a significant increase (Clone #3, 2.5-fold increase, p=0.001) and
decrease (Clone #8, 12-fold decrease, p=0.00001), ANOVA (p<0.001), (Fig 1 A (i-ii)
and B) in invasion through matrigel, compared to the parental MiaPaCa-2 cells. These
two clonal populations also displayed distinct morphological differences (Fig 1 A (iii-
iv)). The invasive cell line, Clone #3 displayed an elongated spindled shaped
morphology, similar to mesenchymal cells. Clone #8, low invasion, was similar to
epithelial cells in tight clustered colonies.
Invasion and adhesion to ECM proteins
Invasion of MiaPaCa-2 and sub-populations, Clone #3 and Clone #8, through a range
of ECM proteins was examined (Fig 2 A). The invasion of MiaPaCa-2 and Clone #3
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is comparable through laminin and fibronectin whereas Clone #8 showed a significant
decrease in invasion, 6.3 and 4.0-fold (p=0.002, p=0.008) through laminin and
fibronectin, respectively, ANOVA (all p<0.001). Low invasion was observed for
Clone #3 through collagens type I and IV; Clone #8 showed significantly decreased
invasion through the collagens (1.6 and 1.6-fold (p=0.03, p=0.02)), ANOVA
(p=0.007, p=0.001). Interestingly, the lowest level of invasion displayed by the cell
lines was through the collagens, type IV and I, which is in agreement with previous
studies indicating MiaPaCa-2 does not express collagen-binding integrins [23]. The
highest level of invasion was observed through fibronectin. Clone #3 also displayed
significantly increased motility (p=0.00005) whereas the motility of Clone #8 was
similar to that of MiaPaCa-2, ANOVA (p<0.001) (Fig 2 A).
The more invasive Clone #3, displays significantly decreased adhesion to matrigel
(p=0.01), laminin (p=0.02), fibronectin (p=0.01) and collagen type IV (p=0.01)
compared to the parental cell line (Fig 2 B). In contrast a significant increase in
adhesion was observed to collagen type I (p=0.003), although the level of adhesion to
the collagens was significantly lower than that to fibronectin or laminin. The less
invasive Clone #8, showed significantly increased adhesion to matrigel (p=0.04) and
laminin (p=0.002). Adhesion to fibronectin and collagen type I were also increased,
but not significantly and adhesion to collagen type IV was decreased significantly
(p=0.001) for Clone #8.
Anoikis and anchorage-independent growth
The evaluation of survival in suspension (anoikis) showed that Clone #3 was resistant
to anoikis compared to the parental cell line, although this difference did not reach
statistical significance (p=0.07). Clone #8 demonstrated a significant sensitivity to
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anoikis (p=0.02) compared to the parental cell line, MiaPaCa-2 (Fig 3 A). Anchorage-
independent growth was assessed using the soft agar assay. MiaPaCa-2 showed
colony formation with an average colony size of 75 µm and percentage colony
forming efficiency (% CFE) of 48%; Clone #3 formed more and larger colonies with
an average size of 120 µm and a %CFE of 69%. In contrast, Clone #8 (low invasion
and high adhesion), showed significantly reduced ability (32% CFE) to form colonies
(p=0.006) and the average size of colonies was 60 µm (Fig 3 B).
Integrin expression
Significant changes in invasion and adhesion to fibronectin and laminin were
observed in the sub-populations. Therefore, expression of integrins β1, α5 and α6,
which are associated with adhesion to laminin and fibronectin were examined in the
cell lines, by immunoblotting (Fig 4 A-C). Beta-actin used as loading control (Fig 4
D). Compared to MiaPaCa-2, Clone #8 showed higher expression of integrins β1 and
α5. Low levels of α6 were detected in Clone #8, while it was undetectable in the
parental MiaPaCa-2 cells. Lower levels of each of the integrins were detected in
Clone #3 compared to Clone #8.
Integrin β1 knockdown
The role of integrin β1 in the low invasive cell line, Clone #8 was investigated using
RNAi. Clone #8 was chosen as it expresses high levels of integrin β1 compared to
Clone #3 (Fig 4 A). Cells were subjected to invasion, motility, adhesion and anoikis
assays following siRNA transfection. SiRNA knockdown of protein was confirmed
by immunoblot (Fig 4 E). Integrin β1 siRNA transfected into Clone #8 resulted in a
significant increase in invasion through matrigel (p=0.005 and p=0.04), ANOVA
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(p=0.006), although invasion through laminin was not significantly altered. Invasion
through fibronectin was significantly increased (p=0.04 and p=0.02), ANOVA
(p=0.02). Motility of Clone #8 after siRNA β1 transfection was also significantly
increased (p=0.01 and p=0.03) compared to the scrambled control, ANOVA
(p=0.003) (Fig 5 A). A significant decrease in adhesion to matrigel (45-47%) was
observed (p=0.02 and p=0.002), ANOVA (p=0.002), while adhesion to fibronectin
(p=0.02 and p=0.04), ANOVA (p=0.01) was significantly decreased with the integrin
β1 siRNA treatment (Fig 5 B). Adhesion to laminin was not altered after transfection
with integrin β1 siRNAs. Anoikis assays were also carried out to investigate whether
the knockdown of integrin β1 had any effect on the survival of Clone #8 in suspension
(Fig 5 C). A significant increase in the percentage of cells surviving in suspension was
observed after treatment with integrin β1 siRNA compared to cells treated with
scrambled control (p=0.01, p=0.003), ANOVA (p=0.005)
Integrin α5 and α6 knockdown
To further evaluate the role of specific integrins in invasion, motility, adhesion and
anoikis, siRNA experiments targeting α5 and α6 integrins were also carried out in
Clone #8 cells (Fig 4 F-G). Transfection of integrin α5 siRNA into Clone #8 resulted
in an increase in invasion through matrigel (p=0.0003, p=0.005), ANOVA (p<0.001)
laminin (p=0.07, p=0.008), ANOVA (p=0.001) and fibronectin (p=0.0002, p=0.0001),
ANOVA (p<0.001) compared to the scrambled control. Transfection of siRNA α6
into Clone #8 resulted in a significant increase in invasion through matrigel
(p=0.00009 and p=0.02), ANOVA (p<0.001) and fibronectin (p=0.004 and p=0.04),
ANOVA (p=0.04), with no significant increase in invasion through laminin (Fig 6 A).
Knockdown of integrin α5 resulted in significantly increased motility, ANOVA
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(p=0.007) while integrin α6 knockdown also increased motility significantly in one
siRNA (p=0.19 and p=0.004), ANOVA (p=0.04) (Fig 6 B).
A slight decrease in adhesion to matrigel and laminin was observed although not
significantly, while a significant reduction in adhesion to fibronectin was observed
after integrin α5 siRNA treatment of Clone #8 cells (p=0.02, p=0.03), ANOVA
(p=0.02). Adhesion to matrigel and fibronectin was not altered with integrin α6
siRNA treatment; however adhesion to laminin was reduced (p=0.08 and p=0.01),
ANOVA (p=0.01) (Fig 6 C). No significant change in anoikis response was observed
after either integrin α5 and α6 siRNA transfection, compared to cells treated with
scrambled control (Fig 6 D).
Discussion
One of the most lethal aspects of pancreatic cancer is its early systemic dissemination
and tumour progression [24]. The inability to diagnose pancreatic cancer at an early
stage has contributed to poor prognosis, as well as the difficulties in treating the
metastatic disease. The exact mechanism of pancreatic invasion and metastasis has
not been fully elucidated and a better understanding of these processes is essential in
treating this disease.
To study the inherent heterogeneity of differing sub-populations within a tumour, we
isolated isogenic clonal populations from the human pancreatic cell line, MiaPaCa-2,
by single cell cloning. Two sub-populations displaying differences in invasion were
further analysed to characterise the in vitro invasive phenotype. Clone #3 was
characterised as highly invasive and motile with decreased adhesion to ECM proteins.
The less invasive Clone #8 displayed increased adhesion to ECM proteins. Neither
clone showed an affinity to collagen type I and IV. Grzesiak et al. [23] previously
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determined that the parental cell line MiaPaCa-2 does not express collagen-binding
integrins α1 and α2, but showed that the cells are metastatic in an orthotopic mouse
model and preferentially migrate on laminin-1. Although collagen type IV constitutes
the major intrinsic component of the extracellular matrix [25], the ability of the clonal
populations in our study to invade or/adhere to matrigel could be due to laminin,
another major component of the ECM, and to a lesser extent fibronectin, which
represents a significant step in metastasis [26]. Changes in adhesive characteristics,
invasion and motility of cells have been suspected to play a role in mediating the
spread of malignant cells.
Clone #3 displays the characteristics of an aggressive cancer, with decreased adhesion
facilitating increased motility and invasion, coupled with the ability to survive and to
form colonies in anchorage independent conditions. These features could be compared
to the in vivo situation where the ability of tumour cells to detach from the primary
tumour, invade through the ECM, survive in the blood stream, and invade and form
tumours at secondary sites, leads to the formation of metastases. Therefore, we
believe that Clone #3 represents an in vitro model of tumour cells with increased
metastatic potential. In contrast Clone #8 appears to be a model of tumour cells with
decreased metastatic potential, showing decreased invasion, increased adhesion,
increased sensitivity to anoikis and reduced ability to grow and form colonies in
anchorage-independent conditions.
Integrins are involved in regulating growth, differentiation, and death by regulating
the interaction between cell and ECM [7]. In pancreatic cancer, links have previously
been established between increased invasion and decreased adhesion to ECM proteins
in vitro and to high metastatic potential in vivo [27-29].
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In general, the loss or gain of expression of individual integrins appears to be
indirectly associated with malignant transformation and involved in tumour
progression and metastasis. Over expression of α5β1 in CHO cells demonstrated
reduced malignancy [30], whereas α2β1 and α3β1 were expressed in non-neoplastic
and fibroadenomas but were low or absent in highly invasive mammary carcinomas
[31]. In our study, Clone #3 showed reduced expression of integrins β1, α5 and α6
compared to Clone #8, which correlates with the reduced adhesion to laminin and
fibronectin, as integrin α5β1 is a receptor for fibronectin and α6β1 is a receptor for
laminin [32, 26]. Integrin β1, α5 and α6 siRNA transfection in Clone #8 resulted in
significantly increased motility and invasion through matrigel and fibronectin, and
reduced adhesion to matrigel and fibronectin. Loss of integrin β1 did not alter the
invasion or adhesion of Clone #8 cells to laminin, but loss of α6 significantly reduced
adhesion to laminin. These results suggest that inhibition of integrin β1 alone is not
sufficient to block adhesion to laminin. Other integrin complexes such as α6β4 [33]
could control laminin-mediated adhesion/invasion in these cells. Gilcrease et al. [34]
showed that α6β4 cross linking in suspended non adherent breast cancer cells resulted
in cell surface clustering of EGFR, increasing EGFR-mediated activation of Rho in
response to EGF, which may lead to tumour cell migration. Knockdown of the
expression of integrin β1 in Clone #8 also revealed a more anoikis resistant
phenotype. Disruption of β1 integrin complexes has previously implicated in
induction of anoikis [35-37]. These experiments support the hypothesis that decreased
expression of these integrins β1, α5 and α6, in Clone #3 plays a role in the aggressive
invasive phenotype observed in vitro. Reduced expression of integrin β1, but not α5
and α6, appears to play an important role in anoikis resistance in this model.
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Therefore, targeting of integrins specific to certain tumours may provide viable
options for therapeutic treatment.
Conclusion
We have established that sub-populations within a pancreatic cancer cell line display
varied invasion and adhesive interactions with ECM proteins. Low adhesion, high
motility and invasion, reduced integrin α5, α6 and β1 expression, anoikis resistance
and anchorage-independent growth in Clone #3 represents a highly invasive
phenotype. This is the first study to report the relationship between invasion,
adhesion, anoikis and anchorage independent colony formation within sub-
populations of a pancreatic cancer cell line. In vivo analysis of these clonal
populations of MiaPaCa-2 will be required to determine if the aggressive invasive
phenotype in vitro correlates with increased metastatic potential in vivo. Further
investigation of this aggressive phenotype may help to identify novel markers and
targets for invasion and metastasis in pancreatic cancer.
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Figure legends
Figure 1: A. Morphology of the highly invasive (i) Clone #3 with elongated and
spindle-like phenotype and low-invasive (ii) Clone #8 with epithelial tight colonies.
Cell invasion assay representing (iii) Clone #3 and (iv) Clone #8 invading through
ECM coated Boyden chamber, stained with crystal violet. Magnification 200×. Scale
bar, 200 µm. B. Total number of invading cells. Results shown are a minimum of
three repeats ± standard deviation (n = 3).
Figure 2: A. Invasion assay of MiaPaCa-2, Clone #3 and Clone #8 through ECM
proteins. Motility assay refers to invasion assay without the presence of ECM. Results
are displayed as the total mean number of cells invading at 200× magnification (n =
3). B. Adhesion of MiaPaCa-2, Clone #3 and Clone #8 to ECM proteins: matrigel,
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laminin, fibronectin, collagen type IV (ANOVA, all p<0.001) and collagen I
(ANOVA p=0.04). Results are expressed as absorbance at 405 nm with a reference
wavelength of 620 nm. Data shown is mean ± standard deviation (n = 3). Student’s t-
test; p ≤ 0.05*, 0.01**, 0.005*** .
Figure 3: A. Percentage survival of MiaPaCa-2, Clones #3 and Clone #8 in
suspension compared to adherent cells, ANOVA (p=0.002). B. Percentage colony
formation efficiency (%CFE) of MiaPaCa-2, Clone #3 and Clone #8 under anchorage-
independent growth conditions, ANOVA (p=0.02). Data shown is mean ± standard
deviation (n=3). Student’s t-test; p ≤ 0.05*, 0.01**, 0.005*** .
Figure 4: Immunoblot of A. Integrin β1 B. Integrin α5 C. Integrin α6 and D. β-actin
used as loading control in MiaPaCa-2, Clone #3 and Clone #8. E. Knockdown of
integrin β1 in Clone #8 cells 48 hours post transfection (siRNAs ITGβ1 #1 and #2). F.
Knockdown of integrin α5 in Clone #8 cells 48 hours post transfection (siRNAs
ITGα5 #1, #2). G. Knockdown of integrin α6 in Clone #8 cells 48 hours post
transfection (siRNAs ITGα6 #1 and #2). H. Beta-actin used as loading control.
Figure 5: A. Invasion of Clone #8 through matrigel, laminin and fibronectin and
motility assay. B. Adhesion assay of Clone #8 to matrigel, laminin and fibronectin. C.
Anoikis assay. Experiments were performed 48 hours post-transfection with two
different exon targeted siRNA integrin Beta 1. Student’s t-test; p ≤ 0.05*, 0.01**,
0.005*** .
Figure 6: A. Invasion through matrigel, laminin and fibronectin. B. Motility assay. C.
Adhesion assay to matrigel, laminin and fibronectin. D. Anoikis assay of Clone #8
control, treated with scrambled siRNA, two independent integrin ITGα5 siRNA
targets and two integrin ITGα6 target siRNAs. Student’s t-test; p ≤ 0.05*, 0.01**,
0.005*** .
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